Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash from operating activities:    
Net Loss $ (1,580,887) $ (5,152,477)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 98,922 48,283
Gain on settlement of debt (64,647)
Stock issued per origination fee 750,000
Stock option expense 447,826
Amortization of debt discounts 2,724,389
Initial fair value of warrant liability 735,347
Warrant derivative gain (2,743,686)
Changes in assets and liabilities:    
Accounts receivable (1,240,489) (41,315)
Contract assets (784,811) 52,880
Prepaid expenses and other current assets 97,964 263,827
Accounts payable 604,096 184,829
Accounts payable-related party 875 (27,538)
Payroll taxes payable 168,125 (295,028)
Accrued expenses (128,948) 258,307
Contract liabilities 2,048,419 (19,215)
Deferred revenue (76,379) (236,262)
Net cash used in operating activities (345,287) (3,562,306)
Cash flows from investing activities:    
Software development costs (60,000)
Purchase of patents/trademarks (13,285)
Purchase of fixed assets (212,393) (41,709)
Net cash used in investing activities (285,678) (41,709)
Cash flows from financing activities:    
Repayments of line of credit (3,312) (3,506)
Repayments of related party notes (48,215) (432,527)
Repayments of insurance and equipment financing (243,566)
Repayments of notes payable (1,766,250)
Repayments of series A convertible stock (319,680)
Repurchase of common stock (1,459)
Proceeds from series B preferred stock 1,000,000
Proceeds from common stock, net 5,777,390
Proceeds from warrants exercised 195,000
Repayments from financing agreements (217,470)
Proceeds of notes payable 1,333,500
Net cash (used in) provided by financing activities (101,552) 5,371,457
Net (decrease) increase in cash (732,517) 1,767,442
Cash, beginning of year 1,941,818 174,376
Cash, end of year 1,209,301 1,941,818
Supplemental Disclosure of Cash Flow Information:    
Interest paid 7,411 126,975
Tax paid
Supplemental Non-Cash Investing and Financing Activities:    
Common stock issued for accrued BOD fees 73,708
Common stock issued for accounts payable 215,000
Common stock issued for related party notes payable 95,000
Common stock issued for loans and convertible notes 2,424,371
Common stock issued for accrued interest and penalties 257,895
Common stock issued for accrued officer salary 72,292 700,543
Accrued interest forgiven related to note payable settlement 20,697
Accrued dividends 17,760
Debt discount related to notes payable 1,571,250
Note issued for financing of insurance premiums $ 242,239 $ 220,760